Top Back to top

Elderly AML: A randomised Phase III study comparing conventional chemotherapy to low dose total body irradiation-based conditioning and hematopoietic stem cell transplantation from related and unrelated donors as consolidation therapy for older patients with AML in 1st complete remission

Study number:
2007-003514-34
Type of transplant:
 
Short title:
HSCT vs CT in Elderly AML
Study status:
Recruiting Patients
Deadline for data collection:
 
Study design:
Randomised, controlled, open, multicentre, phase III trial
Primary objective:
Efficacy of allogeneic related or unrelated heamtopoietic cell transplantation (HCT) after reduced intensityconditioning as a consolidation treatment for elderly patietns with AML in complete remission
Key inclusion criteria:
>=60, <=75 years old
Country:
Australia
Austria
Belgium
France
Germany
Netherlands
Switzerland
Principal investigator:
Dietger Niederwieser
Principal investigator email:
 
EBMT Study coordinator:
Ruzena Uddin

Need help?

The personal data provided will be processed according to the General Data Protection Regulation (GDPR 2016/679 ) and incorporated to a file property of EBMT which will be allocated in the EEA (European Economic Area) or in countries that are provided with the same level of protection for privacy such as countries that adhere to EU-US and Swiss-US Privacy Shield Frameworks.
Data Subjects have the right of access to his or her data and the right to rectification of any inaccurate or incomplete personal data. The Data Subject also has the right to withdraw consent, this wish will be respected, and the personal will no longer be made available. If the processing operation is unlawful the Data Subject has the right to request deletion of that data. Please write to data.protection@ebmt.org